{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:36:02Z","timestamp":1792164962506,"version":"4.4.0"},"reference-count":36,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Advancements in genomic, computing, and imaging technology have spurred new opportunities to use quantitative image analysis (QIA) for diagnostic testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To develop evidence-based recommendations to improve accuracy, precision, and reproducibility in the interpretation of human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) for breast cancer where QIA is used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>The College of American Pathologists (CAP) convened a panel of pathologists, histotechnologists, and computer scientists with expertise in image analysis, immunohistochemistry, quality management, and breast pathology to develop recommendations for QIA of HER2 IHC in breast cancer. A systematic review of the literature was conducted to address 5 key questions. Final recommendations were derived from strength of evidence, open comment feedback, expert panel consensus, and advisory panel review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Eleven recommendations were drafted: 7 based on CAP laboratory accreditation requirements and 4 based on expert consensus opinions. A 3-week open comment period received 180 comments from more than 150 participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>To improve accurate, precise, and reproducible interpretation of HER2 IHC results for breast cancer, QIA and procedures must be validated before implementation, followed by regular maintenance and ongoing evaluation of quality control and quality assurance. HER2 QIA performance, interpretation, and reporting should be supervised by pathologists with expertise in QIA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2018-0378-cp","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T14:15:04Z","timestamp":1547561704000},"page":"1180-1195","source":"Crossref","is-referenced-by-count":72,"title":["Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists"],"prefix":"10.5858","volume":"143","author":[{"given":"Marilyn M","family":"Bui","sequence":"first","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Riben","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly H.","family":"Allison","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Chlipala","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Colasacco","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea G.","family":"Kahn","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lacchetti","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Madabhushi","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Pantanowitz","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Salama","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Stewart","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Thomas","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Tomaszewski","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elizabeth","family":"Hammond","sequence":"additional","affiliation":[{"name":"From the Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Dr Bui); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Riben); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Allison); Premier Laboratory, Longmont, Colorado (Ms Chlipala); Surveys (Mses Colasacco and Thomas), College of Ame"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"key":"2020081203353734000_i1543-2165-143-10-1180-b01","article-title":"U.S. Breast Cancer Statistics","author":"Breastcancer.org","year":"2018","journal-title":"Breastcancer.org Web site"},{"issue":"20","key":"2020081203353734000_i1543-2165-143-10-1180-b02","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b03","unstructured":"College of American Pathologists. Surveys and Anatomic Pathology Education Programs: Histotechnology Quality Improvement Program HQIP-A 2016. Northfield, IL: College of American Pathologists;2016."},{"key":"2020081203353734000_i1543-2165-143-10-1180-b04","first-page":"S23","article-title":"Comparison of Companion Virtuoso and stand-alone Visiopharm breast marker image analysis software [Pathology Informatics 2015]","volume":"6","author":"Combrinck","year":"2015","journal-title":"J Pathol Inform"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b05","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/jpi.jpi_46_17","article-title":"Impact of altering various image parameters on human epidermal growth factor receptor 2 image analysis data quality","volume":"8","author":"Pantanowitz","year":"2017","journal-title":"J Pathol Inform"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b06","unstructured":"Institute of Medicine (IOM). Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press;2011."},{"key":"2020081203353734000_i1543-2165-143-10-1180-b07","unstructured":"The Global Harmonization Task Force Study Group 3. Quality Management Systems \u2013 Process Validation Guidance. 2nd ed. http:\/\/www.imdrf.org\/docs\/ghtf\/final\/sg3\/technical-docs\/ghtf-sg3-n99-10-2004-qms-process-guidance-04010.pdf#search=\u201dprocess validation\u201d. Published January 2004. AccessedJuly16,2018."},{"key":"2020081203353734000_i1543-2165-143-10-1180-b08","article-title":"Accreditation checklists. College of American Pathologists Web site","author":"College of American Pathologists","year":"2018"},{"issue":"11","key":"2020081203353734000_i1543-2165-143-10-1180-b09","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.5858\/arpa.2013-0610-CP","article-title":"Principles of analytic validation of immunohistochemical assays: guideline from the College of American Pathologists Pathology and Laboratory Quality Center","volume":"138","author":"Fitzgibbons","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2020081203353734000_i1543-2165-143-10-1180-b10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.5858\/134.6.930","article-title":"Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays","volume":"134","author":"Fitzgibbons","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b11","unstructured":"US Food and Drug Administration. Analytical Procedures and Methods Validation for Drugs and Biologics: Guidance for Industry. Silver Spring, MD: US Food and Drug Administration, US Department of Health and Human Services;2015."},{"issue":"4","key":"2020081203353734000_i1543-2165-143-10-1180-b12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1158\/1055-9965.EPI-09-1023","article-title":"Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies","volume":"19","author":"Bolton","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2020081203353734000_i1543-2165-143-10-1180-b13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2559.2011.03878.x","article-title":"Cell-based quantification of molecular biomarkers in histopathology specimens","volume":"59","author":"Al-Kofahi","year":"2011","journal-title":"Histopathology"},{"issue":"4","key":"2020081203353734000_i1543-2165-143-10-1180-b14","doi-asserted-by":"crossref","first-page":"e0123201","DOI":"10.1371\/journal.pone.0123201","article-title":"Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study","volume":"10","author":"van der Logt","year":"2015","journal-title":"PLoS One"},{"issue":"16","key":"2020081203353734000_i1543-2165-143-10-1180-b15","first-page":"3707","article-title":"Clinical Laboratory Improvement Amendments of 1988; final rule. Standard: establishment and verification of performance specifications","volume":"68","author":"Department of Health and Human Services, Centers for Medicare and Medicaid Services","year":"2003","journal-title":"Fed Regist"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b16","first-page":"6","article-title":"Selection and analytical evaluation of methods \u2013 with statistical techniques","author":"Linnet","year":"2015","journal-title":"Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics. 7th ed"},{"issue":"2","key":"2020081203353734000_i1543-2165-143-10-1180-b17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5858\/135.2.233","article-title":"Observer variability in the interpretation of HER2\/neu immunohistochemical expression with unaided and computer-aided digital microscopy","volume":"135","author":"Gavrielides","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"2020081203353734000_i1543-2165-143-10-1180-b18","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.5858\/133.9.1413","article-title":"Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis","volume":"133","author":"Gustavson","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2020081203353734000_i1543-2165-143-10-1180-b19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1309\/AJCP9MKNLHQNK2ZX","article-title":"Image analysis of HER2 immunohistochemical staining: reproducibility and concordance with fluorescence in situ hybridization of a laboratory-validated scoring technique","volume":"137","author":"Minot","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"2020081203353734000_i1543-2165-143-10-1180-b20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.5858\/2010-0418-OAR1.1","article-title":"Trainable immunohistochemical HER2\/neu image analysis: a multisite performance study using 260 breast tissue specimens","volume":"135","author":"Nassar","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"2020081203353734000_i1543-2165-143-10-1180-b21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5306\/wjco.v2.i4.187","article-title":"Automation of immunohistochemical evaluation in breast cancer using image analysis","volume":"2","author":"Prasad","year":"2011","journal-title":"World J Clin Oncol"},{"issue":"1","key":"2020081203353734000_i1543-2165-143-10-1180-b22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2478\/v10042-010-0015-1","article-title":"Study on breast carcinoma Her2\/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio)","volume":"48","author":"Slodkowska","year":"2010","journal-title":"Folia Histochem Cytobiol"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2407-9-165","article-title":"Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis","volume":"9","author":"Turashvili","year":"2009","journal-title":"BMC Cancer"},{"issue":"10","key":"2020081203353734000_i1543-2165-143-10-1180-b24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1309\/LMA2M9NQQF0ZCVHC","article-title":"Digital pathology: a regulatory overview","volume":"42","author":"Lange","year":"2011","journal-title":"Lab Med"},{"issue":"7","key":"2020081203353734000_i1543-2165-143-10-1180-b25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.5858\/arpa.2014-0127-OA","article-title":"Evaluation of HER2\/neu status by immunohistochemistry using computer-based image analysis and correlation with gene amplification by fluorescence in situ hybridization assay: a 10-year experience and impact of test standardization on concordance rate","volume":"139","author":"Sarode","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"2020081203353734000_i1543-2165-143-10-1180-b26","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1007\/s13277-015-4327-9","article-title":"Application of multispectral imaging in quantitative immunohistochemistry study of breast cancer: a comparative study","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol"},{"issue":"5","key":"2020081203353734000_i1543-2165-143-10-1180-b27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/PAS.0000000000000375","article-title":"Quantification of human epidermal growth factor receptor 2 immunohistochemistry using the Ventana Image Analysis System: correlation with gene amplification by fluorescence in situ hybridization: the importance of instrument validation for achieving high (&gt;95%) concordance rate","volume":"39","author":"Dennis","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2020081203353734000_i1543-2165-143-10-1180-b28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jcp.2011.089847","article-title":"HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods","volume":"64","author":"Bartlett","year":"2011","journal-title":"J Clin Pathol"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b29","article-title":"Definition: image metadata. WhatIs.com Web site","author":"Rouse","year":"2018"},{"issue":"26","key":"2020081203353734000_i1543-2165-143-10-1180-b30","first-page":"S48","article-title":"Whole slide image file integrity: a 10-year look back at archival images [Pathology Informatics Summit 2017]","volume":"8","author":"Hanna","year":"2017","journal-title":"J Pathol Inform"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b31","first-page":"153","article-title":"Image analysis applications","author":"Conway","year":"2017","journal-title":"Digital Pathology"},{"issue":"6","key":"2020081203353734000_i1543-2165-143-10-1180-b32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/amiajnl-2012-001540","article-title":"Pathology imaging informatics for quantitative analysis of whole-slide images","volume":"20","author":"Kothari","year":"2013","journal-title":"J Am Med Inform Assoc"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/2153-3539.158066","article-title":"Comparative study between quantitative digital image analysis and fluorescence in situ hybridization of breast cancer equivocal human epidermal growth factor receptors 2 score 2(+) cases","volume":"6","author":"Ayad","year":"2015","journal-title":"J Pathol Inform"},{"issue":"2","key":"2020081203353734000_i1543-2165-143-10-1180-b34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10549-015-3475-3","article-title":"Optimizing HER2 assessment in breast cancer: application of automated image analysis","volume":"152","author":"Holten-Rossing","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"2020081203353734000_i1543-2165-143-10-1180-b35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-007-0400-0","article-title":"Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count","volume":"450","author":"Tawfik","year":"2007","journal-title":"Virchows Arch"},{"key":"2020081203353734000_i1543-2165-143-10-1180-b36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.media.2016.06.037","article-title":"Image analysis and machine learning in digital pathology: challenges and opportunities","volume":"33","author":"Madabhushi","year":"2016","journal-title":"Med Image Analysis"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/10\/1180\/2368138\/arpa_2018-0378-cp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/10\/1180\/2368138\/arpa_2018-0378-cp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:35:07Z","timestamp":1764790507000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/143\/10\/article-p1180.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,1,15]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2018-0378-cp","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]}}}